BACKGROUND: Historically, treatment efficacy of professional baseball injuries has been determined by assessing the return-to-play (RTP) rate or using patient-reported functional outcomes scores; however, these methods may not be sensitive and specific enough for elite athletes. As a consequence, performance-based statistics are increasingly being reported in the medical literature. PURPOSE: To (1) assess how treatment efficacy is currently reported in professional baseball players; (2) examine the variability in the reporting of these measures in terms of frequency, length of time followed, and units of measure; and (3) identify any attempts to validate these performance-based statistics. STUDY DESIGN: Systematic review. METHODS: All studies reporting treatment efficacy in professional baseball in PubMed, Embase, and Cochrane were identified. Data collected included frequency and method of reporting: RTP, functional outcomes, and performance-based statistics. RESULTS: Fifty-four studies met all inclusion criteria. Of these, 51 (94%) reported RTP, 12 (22%) utilized functional outcomes, and 18 (33%) provided baseball-specific performance-based statistics to assess treatment efficacy. Great variability was seen in how follow-up was defined (games, seasons, months), duration of follow-up, and which performance-based statistics were utilized. None of the studies validated these performance-based statistics, determined minimal time of follow-up needed, or assessed the baseline variability in these statistics among noninjured players. CONCLUSION: Most studies reported RTP to determine treatment efficacy, but significant variability was seen in how players were followed. Similarly, great variability was noted in the type and number of performance-based statistics utilized. Additional studies are necessary to validate these measures and determine the appropriate length of time that they should be followed. CLINICAL RELEVANCE: This study provides a clear overview of the current methods that are used to determine treatment efficacy in professional baseball players.
BACKGROUND: Historically, treatment efficacy of professional baseball injuries has been determined by assessing the return-to-play (RTP) rate or using patient-reported functional outcomes scores; however, these methods may not be sensitive and specific enough for elite athletes. As a consequence, performance-based statistics are increasingly being reported in the medical literature. PURPOSE: To (1) assess how treatment efficacy is currently reported in professional baseball players; (2) examine the variability in the reporting of these measures in terms of frequency, length of time followed, and units of measure; and (3) identify any attempts to validate these performance-based statistics. STUDY DESIGN: Systematic review. METHODS: All studies reporting treatment efficacy in professional baseball in PubMed, Embase, and Cochrane were identified. Data collected included frequency and method of reporting: RTP, functional outcomes, and performance-based statistics. RESULTS: Fifty-four studies met all inclusion criteria. Of these, 51 (94%) reported RTP, 12 (22%) utilized functional outcomes, and 18 (33%) provided baseball-specific performance-based statistics to assess treatment efficacy. Great variability was seen in how follow-up was defined (games, seasons, months), duration of follow-up, and which performance-based statistics were utilized. None of the studies validated these performance-based statistics, determined minimal time of follow-up needed, or assessed the baseline variability in these statistics among noninjured players. CONCLUSION: Most studies reported RTP to determine treatment efficacy, but significant variability was seen in how players were followed. Similarly, great variability was noted in the type and number of performance-based statistics utilized. Additional studies are necessary to validate these measures and determine the appropriate length of time that they should be followed. CLINICAL RELEVANCE: This study provides a clear overview of the current methods that are used to determine treatment efficacy in professional baseball players.
Authors: William A Zuke; Avinesh Agarwalla; Beatrice Go; Justin W Griffin; Brian J Cole; Nikhil N Verma; Bernard R Bach; Brian Forsythe Journal: Knee Surg Sports Traumatol Arthrosc Date: 2018-06-28 Impact factor: 4.342
Authors: Prem N Ramkumar; Sergio M Navarro; Heather S Haeberle; Rowland W Pettit; Travis J Miles; Salvatore J Frangiamore; Michael A Mont; Lutul D Farrow; Mark S Schickendantz Journal: Orthop J Sports Med Date: 2018-12-13
Authors: Ayoosh Pareek; Chad W Parkes; Alexey A Leontovich; Aaron J Krych; Stan Conte; John A Steubs; Corey A Wulf; Christopher L Camp Journal: Orthop J Sports Med Date: 2021-11-18
Authors: Christopher M LaPrade; Mark E Cinque; Marc R Safran; Michael T Freehill; Corey A Wulf; Robert F LaPrade Journal: Orthop J Sports Med Date: 2022-07-20